Month: January 2025

KUALA LUMPUR, Malaysia, Jan. 07, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global,” or the “Company”), today announced the carve-out of its wholly owned subsidiary, V Capital Consulting Group Limited (“VCCG”), for listing on the Nasdaq Capital Market. VCIG will retain majority control of VCCG. This strategic initiative aims to enable both companies to focus on their core competencies, better serve their respective markets, and enhance growth potential and value creation for shareholders. The carve-out has been executed pursuant to the Stock Sale and Business Separation Agreement entered into on December 30, 2024, through the sale of VCI Global’s subsidiaries V Capital Consulting Limited and V Capital Advisory Sdn. Bhd. to VCCG. This strategic move is designed to unlock value for shareholders by allowing both...

Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth Initiatives LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) — Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced the appointment of Nathen Fuentes, CPA, as Chief Financial Officer effective January 2, 2025, replacing interim CFO Simon Tarsh. Nathen Fuentes comes to Renovaro as a senior biotechnology and specialty healthcare financial executive with a depth and breadth of functional and industry experiences based upon progressively senior strategic, operational and financial leadership roles. Mr. Fuentes has experience leading acquisition and organic growth initiatives within highly levered environments while managing investor...

SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025 at 4:30pm PT / 7:30pm ET. A live webcast of the presentation will be available on the investor section of the Anaptys website at http://ir.anaptysbio.com/events. A replay of the webcast will be available for at least 30 days following the event. About Anaptys Anaptys is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. Its lead program, rosnilimab, a depleter and agonist targeting PD-1+ T cells, is...

REC-3565 is a potential best-in-class MALT1 inhibitor for multiple hematology indications, designed to reduce the risk of hyperbilirubinemia, a common side effect of other MALT1 inhibitors REC-4539, a potential best-in-class LSD1 inhibitor, is the first designed to be reversible and CNS penetrant for small-cell lung cancerSalt Lake City, UT, Jan. 07, 2025 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has cleared a clinical trial application (CTA) for a Phase 1 clinical trial of REC-3565, a potential best-in-class MALT1 inhibitor for B-cell malignancies. For REC-3565, the total addressable population could include a range of hematological indications,...

RONKONKOMA, N.Y., Jan. 07, 2025 (GLOBE NEWSWIRE) — SUNation Energy, Inc. (Nasdaq: SUNE), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that its Board of Directors has approved the inclusion of bitcoin (BTC) as an asset in the Company’s treasury management program. As part of this strategy, SUNation plans to allocate up to 30% of its excess cash, calculated based on its estimated six-month operating expenses, toward BTC purchases. This allocation will be subject to, among other factors, market conditions and the Company’s operational requirements, including in support of its planned expansion strategy. Strategic Diversification and Innovation Bitcoin, recognized as a decentralized store of value, has been adopted to diversify the Company’s...

Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) — Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today issued a letter to shareholders from Chief Executive Officer David Weinstein. Dear Shareholders, As we enter the new year, I wanted to update you on the progress we have made in the last two months and further define our trajectory for 2025. Our comprehensive analysis of both businesses and development of a 100-day plan of action has already turned up some hidden value in both businesses and is helping us understand key areas of the business we need to fortify. We have identified three areas as mission critical for building the point of care cancer detection, personalized therapy and vaccine business...

Knoxville, TN, Jan. 07, 2025 (GLOBE NEWSWIRE) — Healthcare Integrated Technologies (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the appointment of Justin Freishtat as its Chief Capital Officer. Mr. Freishtat spent the first decade of his professional career building Heartland Foods, which is the premier farm-to-table food service company on the east coast. The Company generated in excess of $87 million in gross revenue, when it was acquired by a private equity firm in 2022. Mr. Freishtat was a Managing Partner and President of Sales at Kerns Capital and Marketing. Kerns Capital has several funds that utilize multiple strategies, including trading, joint ventures in real estate development and several unicorn companies in late state private equity. The Marketing segment of Kerns,...

MONROE, Mich., Jan. 07, 2025 (GLOBE NEWSWIRE) — La-Z-Boy Incorporated (NYSE: LZB), a global leader in the retail and manufacture of residential furniture, today announced that Melinda D. Whittington, Board Chair, President and Chief Executive Officer, and Taylor Luebke, SVP and Chief Financial Officer, will present at the 2025 ICR Conference. The event will be held on Monday, January 13, 2025, at 4:30 p.m. Eastern Time. The presentation will be webcast live and archived at https://lazboy.gcs-web.com/. Investor Relations Contact:Mark Becks, CFA, (734) 457-9538mark.becks@la-z-boy.com About La-Z-Boy:La-Z-Boy Incorporated brings the transformational power of comfort to people, homes, and communities around the world – a mission that began when its founders invented the iconic recliner in 1927. Today, the company operates as a...

Hod Hasharon, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced that its management will be meeting with investors and presenting at the Needham Growth Conference taking place in New York on January 15, 2025.   Allot’s CEO, Eyal Harari will be presenting on Wednesday, January 15, 2015 at 1:30p.m. ET and will also be available for one-on-one or group meetings that day. For more information about the conference, or to schedule a meeting with Allot’s management, please contact your Needham representative or email the investor relations team at Allot. About Allot Allot Ltd. (NASDAQ: ALLT, TASE: ALLT) is a provider of leading innovative network intelligence...

Stellantis Partners with dSPACE to Accelerate Cloud-based Development of VehiclesPartnership with dSPACE will provide Stellantis with a powerful simulation platform to drive faster and higher-quality software innovations Cloud-based development, integration and validation enable Stellantis engineers to start testing and developing software up to a year before production hardware is available dSPACE solutions are integral to the Stellantis Virtual Engineering Workbench (VEW), streamlining software development cyclesAMSTERDAM, January 7, 2025 – Stellantis, one of the world’s leading automakers, and dSPACE, a leader in simulation and validation solutions, today announced they have signed a non-binding Memorandum of Understanding (MOU) aimed at accelerating the cloud-based development of Stellantis vehicles. The collaboration will integrate...